A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome

By sjmartinez • February 7, 2024

Hammond TC, Purbhoo MA, Kadel S, Ritz J, Nikiforow S, Daley H, Shaw K, van Besien K, Gomez-Arteaga A, Stevens D, Ortuzar W, Michelet X, Smith R, Moskowitz D, Masakayan R, Yigit B, Boi S, Soh KT, Chamberland J, Song X, Qin Y, Mishchenko I, Kirby M, Nasonenko V, Buffa A, Buell JS, Chand D, van Dijk M, Stebbing J, Exley MA. A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome. Nat Commun. 2024 Feb 6;15(1):974. doi: 10.1038/s41467-024-44905-z. PMID: 38321023.

Tags: Publications, Pulmonary, Critical Care & Sleep Medicine

Cardiovascular disease mortality among women diagnosed with de novo metastatic breast cancer

Ramin C, Gresham G, Li J, Karlstaedt A, Hashibe M, Nikolova AP, Atkins KM. Cardiovascular disease mortality among women diagnosed with de novo metastatic breast[...]

Catheter Ablation of Ventricular Tachycardia via the Coronary Veins

Mori S, Hayase JH, Miyazaki Y, Yamagami S, Kawaji T, Shivkumar K. Catheter Ablation of Ventricular Tachycardia via the Coronary Veins. Indian Pacing Electrophysiol J.[...]

Brain Tissue Changes, Network Dysfunctions, and Cerebral Hemodynamic Deficits in Postural Orthostatic Tachycardia Syndrome

Malik V, Roy B, Sarkar A, Shivkumar K, Khalsa S, Kumar R, Ajijola OA. Brain Tissue Changes, Network Dysfunctions, and Cerebral Hemodynamic Deficits in Postural[...]